Henry Schein, Inc. (NASDAQ:HSIC) – Investment analysts at Leerink Swann lifted their FY2018 EPS estimates for shares of Henry Schein in a report issued on Tuesday. Leerink Swann analyst D. Larsen now anticipates that the company will post earnings of $4.10 per share for the year, up from their previous estimate of $3.85. Leerink Swann has a “Hold” rating and a $75.00 price target on the stock.
HSIC has been the subject of several other research reports. Zacks Investment Research raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, January 4th. Royal Bank of Canada reduced their price objective on shares of Henry Schein from $91.00 to $82.00 and set a “sector perform” rating for the company in a research note on Tuesday, November 7th. Stephens began coverage on shares of Henry Schein in a research note on Tuesday, November 28th. They set an “equal weight” rating and a $76.00 price objective for the company. Barrington Research reaffirmed an “outperform” rating on shares of Henry Schein in a research note on Wednesday. Finally, Morgan Stanley cut shares of Henry Schein from an “equal weight” rating to an “underweight” rating and set a $88.00 price objective for the company. in a research note on Wednesday, December 6th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and eight have assigned a buy rating to the company. Henry Schein presently has a consensus rating of “Hold” and an average target price of $83.57.
Henry Schein (NASDAQ:HSIC) opened at $68.05 on Friday. The company has a market cap of $10,690.00, a P/E ratio of 19.55, a P/E/G ratio of 1.69 and a beta of 1.00. Henry Schein has a 12 month low of $63.01 and a 12 month high of $93.50. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.86 and a current ratio of 1.45.
Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, February 20th. The company reported $0.97 EPS for the quarter, meeting the consensus estimate of $0.97. The company had revenue of $3.32 billion during the quarter, compared to analysts’ expectations of $3.30 billion. Henry Schein had a net margin of 3.26% and a return on equity of 19.70%. Henry Schein’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.94 earnings per share.
Institutional investors have recently made changes to their positions in the business. Generation Investment Management LLP lifted its holdings in shares of Henry Schein by 561.1% in the 4th quarter. Generation Investment Management LLP now owns 11,026,174 shares of the company’s stock worth $770,509,000 after acquiring an additional 9,358,345 shares during the last quarter. Alecta Pensionsforsakring Omsesidigt lifted its holdings in shares of Henry Schein by 112.0% in the 3rd quarter. Alecta Pensionsforsakring Omsesidigt now owns 5,313,980 shares of the company’s stock worth $435,693,000 after acquiring an additional 2,806,990 shares during the last quarter. Mackenzie Financial Corp lifted its holdings in shares of Henry Schein by 53.0% in the 4th quarter. Mackenzie Financial Corp now owns 6,023,557 shares of the company’s stock worth $420,926,000 after acquiring an additional 2,085,324 shares during the last quarter. Janus Henderson Group PLC lifted its holdings in shares of Henry Schein by 92.1% in the 3rd quarter. Janus Henderson Group PLC now owns 2,814,636 shares of the company’s stock worth $230,777,000 after acquiring an additional 1,349,333 shares during the last quarter. Finally, Atlanta Capital Management Co. L L C lifted its holdings in shares of Henry Schein by 99.4% in the 3rd quarter. Atlanta Capital Management Co. L L C now owns 2,493,054 shares of the company’s stock worth $204,405,000 after acquiring an additional 1,242,849 shares during the last quarter. Institutional investors and hedge funds own 88.58% of the company’s stock.
In other Henry Schein news, Director Barry J. Alperin sold 5,796 shares of Henry Schein stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $70.76, for a total transaction of $410,124.96. Following the completion of the sale, the director now directly owns 48,172 shares in the company, valued at $3,408,650.72. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 1.19% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This piece of content was originally reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece of content on another domain, it was stolen and republished in violation of international trademark and copyright laws. The original version of this piece of content can be accessed at https://ledgergazette.com/2018/02/24/fy2018-earnings-forecast-for-henry-schein-inc-hsic-issued-by-leerink-swann.html.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.